Antimicrobial activity of ceftazidime-avibactam tested against Pseudomonas aeruginosa from China (2009-2010)

被引：0
|
作者：
Flamm, R. K. [1 ]
Jones, R. N. [1 ]
Sader, H. S. [1 ]
Wang, Y. [2 ]
Xu, Y. [2 ]
机构：
[1] JMI Labs, North Liberty, IA USA
[2] Peking Union Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2013年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] Activity of Ceftazidime-Avibactam against Fluoroquinolone-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
    Pitart, C.
    Marco, F.
    Keating, T. A.
    Nichols, W. W.
    Vila, J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 3059 - 3065
  • [2] Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from US Medical Centers, 2013 to 2016
    Sader, Helio S.
    Castanheira, Mariana
    Shortridge, Dee
    Mendes, Rodrigo E.
    Flamm, Robert K.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (11)
  • [3] Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa
    Nichols, Wright W.
    Stone, Gregory G.
    Newell, Paul
    Broadhurst, Helen
    Wardman, Angela
    MacPherson, Merran
    Yates, Katrina
    Riccobene, Todd
    Critchley, Ian A.
    Das, Shampa
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [4] CEFTAZIDIME-AVIBACTAM AND AZTREONAM AGAINST MULTIDRUG- RESISTANT PSEUDOMONAS AERUGINOSA
    Toor, Rebecca
    Garcia, Esther
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [5] Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model
    Housman, Seth T.
    Crandon, Jared L.
    Nichols, Wright W.
    Nicolau, David P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1365 - 1371
  • [6] Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China
    Wang, Qi
    Zhang, Feifei
    Wang, Zhanwei
    Chen, Hongbin
    Wang, Xiaojuan
    Zhang, Yawei
    Li, Shuguang
    Wang, Hui
    [J]. BMC MICROBIOLOGY, 2020, 20 (01)
  • [7] ANTIMICROBIAL ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COMPARATOR AGENTS AGAINST PSEUDOMONAS AERUGINOSA AND ENTEROBACTERALES CAUSING PNEUMONIA IN CYSTIC FIBROSIS PATIENTS
    Duncan, L. R.
    Streit, J. M.
    Castanheira, M.
    Sader, H. S.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S162 - S162
  • [8] Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China
    Qi Wang
    Feifei Zhang
    Zhanwei Wang
    Hongbin Chen
    Xiaojuan Wang
    Yawei Zhang
    Shuguang Li
    Hui Wang
    [J]. BMC Microbiology, 20
  • [9] Genomic epidemiology and ceftazidime-avibactam high-level resistance mechanisms of Pseudomonas aeruginosa in China from 2010 to 2022
    Li, Xi
    Zhou, Longjie
    Lei, Tailong
    Zhang, Xiaofan
    Yao, Jiayao
    He, Jintao
    Liu, Haiyang
    Cai, Heng
    Ji, Jingshu
    Zhu, Yiwei
    Tu, Yuexing
    Yu, Yunsong
    Zhou, Hua
    [J]. EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [10] Evaluation of the In vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
    Bilgin, Melek
    Basbulut, Ese
    Isler, Hacer
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 713 - 719
12345